Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides

Molecular Cancer Therapeutics

Volumn 3, Issue 1, 2004, Pages 85-91

  Kurizaki, Takashi ^a   Abe, Michio ^a   Sanderson, Sam D ^a   Enke, Charles A ^a   Baranowska Kortylewicz, Janina ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR AGONIST; CYCLOOXYGENASE 2 INHIBITOR; DRUG VEHICLE; IMMUNOGLOBULIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IODINE 125; MONOCLONAL ANTIBODY B.72.3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PADGEM PROTEIN; PEPTIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG SELECTIVITY; DRUG UPTAKE; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRAVASATION; FEMALE; HUMAN; HUMAN CELL; LEUKOPENIA; MEASUREMENT; MEDIATOR; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CHO CELLS; COMPLEMENT C5A; CRICETINAE; CRICETULUS; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; FEMALE; GRANULOCYTES; GUANIDINES; HUMANS; INDOMETHACIN; MICE; MICE, NUDE; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROBENZENES; OLIGOPEPTIDES; P-SELECTIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN BINDING; RECEPTOR, ANAPHYLATOXIN C5A; SULFONAMIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 4444365309     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Morgan EL. Complement fragment C5a and immunoregulation. In: Cruse JM, Lewis RE Jr, editors. Complement today. Karger: Basel; 1993. vol 1. p. 56-75.
2. Buchner RR, Hugli TE, Ember JA, Morgan EL. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J Immunol. 1995;155:308-15.
3. Haviland DL, McCoy RL, Whitehead WT, Akama H, Molmenti EP, Brown A, et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol. 1995;154:1861-9.
4. Williams TJ. Vascular permeability changes induced by complement-derived peptides. Agents Actions. 1983;13:451-5.
5. Sanderson SO, Kirnarsky L, Sherman SA, Vogen SM, Prakash O, Ember JA, et al. Decapeptide agonists of human C5a: the relationship between conformation and neutrophil responses. J Med Chem. 1995;38:3669-75.
6. Kawatsu R, Sanderson SD, Blanco I, Kendall N, Finch AM, Taylor SM, et al. Conformationally biased analogues of human C5a mediate changes in vascular permeability. J Pharmacol Exp Ther. 1996;278:432-40.
7. Kurizaki T, Okazaki S, Sanderson SD, Tempero MA, Colcher D, Enke CA, et al. Potentiation of radioimmunotherapy of colorectal cancer with response-selective agonist of human C5a. J Nucl Med. 2002;43:957-67.
8. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem. 1999;274:24930-4.
9. Jagels MA, Daffern PJ, Hugh TE. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunapharmacology. 2000;46:209-22.
10. Short AJ, Paczkowski N, Vogen SM, Sanderson SD, Taylor SM. Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat. Br J Pharmacol. 1999;128:511-14.
11. Fujii E, Irie K, Ogawa A, Ohba K, Muraki T. Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur J Pharmacol. 1996;297:257-63.
12. Fujii E, Irie K, Ohba K, Ogawa A, Yoshioka T, Yamakawa M, et al. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch Pharmacol. 1997;356:475-80.
13. Ley K, Bullard DC, Arbones ML, Bosse R, Vestweber D, Tedder TF, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med. 1995;181:669-75.
14. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298(Pt 2):249-58.
15. Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B. Inhibition of nitric oxide synthesis by Nω-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, Nω-nitro-L-arginine. Br J Pharmacol. 1996;118:1433-40.
16. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 1993;233:119-25.
17. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J. 1995;305:479-84.
18. Vogen SM, Finch AM, Wadi SK, Thatcher J, Monk PN, Taylor SM, et al. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity. J Pept Res. 1999;53:8-17.
19. Han Y, Cutler JE. Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis. 1997;175:1169-75.
20. Mehrad B, Moore TA, Standiford TJ. Macrophage inflammatory protein-1a is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J Immunol. 2000;165:962-8.
21. Smith MJ, Berg EL, Lawrence MB. A direct comparison of selectin-mediated transient, adhesive events using high temporal resolution. Biophys J. 1999;77:3371-83.
22. Ohnishi M, Imanishi N. Role of P-selectin in the migration of neutrophils to chemoattractant-induced cutaneous inflammation in mice. Inflammation. 2000;24:583-93.
23. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 1994;47:55-9.
24. Buchsbaum DJ. Experimental approaches to increase radiolabeled antibody localization in tumors. Cancer Res. 1995;55:5729s-32s.
25. DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, et al. The biologic window for chimeric L6 radioimmunotherapy. Cancer. 1994;73:1023-32.
26. Blumenthal RD, Sharkey RM, Kashi R, Natale AM, Goldenberg DM. Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas. Int J Cancer. 1992;51:935-41.
27. Takano T, Clish CB, Gronert K, Petasis N, Serhan CN. Neutrophilmediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest. 1998;101:819-26.
28. Todderud G, Alford J, Aruffo A, Tramposch K. Phorbol ester-induced upregulation of polymorphonuclear leukocyte P-selectin ligand expression. Cell Immunol. 1995;166:16-24.
29. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 1994;94:1147-55.
30. Luo HY, Wead WB, Yang S, Wilson MA, Harris PD. Nitric oxide mediates C5a-induced vasodilation in the small intestine. Microcirculation. 1995;2:53-61.
31. Corriveau CC, Madara PJ, Van Dervort AL, Tropea MM, Wesley RA, Danner RL. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils. J Infect Dis. 1997;177: 116-26.
32. Lundberg C, Marceau F, Hugli TE. C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol. 1987;128:471-83.